NR1H4 and Hepatic steatosis: In an animal model, FXR-null mice have been shown to develop dyslipidemia and hepatic steatosis, and they exhibit a proatherogenic lipoprotein profile with markedly elevated serum and hepatic cholesterol and triglycerides [79].